BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4200542)

  • 1. Effect of heat-labile factors on the neutralization of vaccinia virus by human.
    Takabayashi K; McIntosh K
    Infect Immun; 1973 Oct; 8(4):582-9. PubMed ID: 4200542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat-labile accessory factor involved in vaccinia virus plaque neutralization.
    O'Brien TC; Hannah JE; Tauraso NM
    Arch Gesamte Virusforsch; 1973; 40(3):366-74. PubMed ID: 4735532
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccinia virus strain differences. I. Neutralization of vaccinia virus strains by homologous and heterologous antisera.
    Dunlap RC; Barker LF
    Arch Gesamte Virusforsch; 1973; 42(2):107-16. PubMed ID: 4126981
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
    Leddy JP; Simons RL; Douglas RG
    J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the early antigens induced by vaccinia virus.
    Ueda Y; Tagaya I; Amano H; Ito M
    Virology; 1972 Sep; 49(3):794-800. PubMed ID: 4627344
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of unheated guinea-pig serum on the neutralization of Semliki Forest virus by various antisera.
    Osterrieth PM
    J Hyg (Lond); 1966 Mar; 64(1):33-44. PubMed ID: 4956521
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunofluorescence test for persistent poxvirus antibodies.
    Gispen R; Huisman J; Brand-Saathof B; Hekker AC
    Arch Gesamte Virusforsch; 1974; 44(4):391-5. PubMed ID: 4212070
    [No Abstract]   [Full Text] [Related]  

  • 8. Experiences with improvement of the neutralization reaction with vaccinia virus in chick fibroblast cultures.
    Aksenov OA; Smorodintsev AA
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(4):488-98. PubMed ID: 6006816
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of staphylococcal protein A with virus-IgG complexes.
    Austin RM; Daniels CA
    J Immunol; 1974 Nov; 113(5):1568-74. PubMed ID: 4371490
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccinia virus strain differences. II. Altered dermal reactivity of vaccinia virus by single passage in a new host system.
    Dunlap RC; Barker LF
    Arch Gesamte Virusforsch; 1973; 42(2):117-24. PubMed ID: 4747046
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence.
    Isaacs SN; Kotwal GJ; Moss B
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):628-32. PubMed ID: 1731333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage antibodies neutralize vaccinia virus.
    Tikunova NV; Belanov EF; Morozova VV; Batanova TA; Bormotov NI; Ovechkina LG; Ilyichev AA; Sandakhchiev LS
    Dokl Biochem Biophys; 2002; 382():10-2. PubMed ID: 11938659
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.
    Newman FK; Frey SE; Blevins TP; Mandava M; Bonifacio A; Yan L; Belshe RB
    J Clin Microbiol; 2003 Jul; 41(7):3154-7. PubMed ID: 12843056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library.
    Shin YW; Chang KH; Hong GW; Yeo SG; Jee Y; Kim JH; Oh MD; Cho DH; Kim SH
    J Microbiol Biotechnol; 2019 Apr; 29(4):651-657. PubMed ID: 30856707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral and cell-mediated immune responses in humans before and after revaccination with vaccinia virus.
    Møller-Larsen A; Haahr S
    Infect Immun; 1978 Jan; 19(1):34-9. PubMed ID: 624594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees.
    Viner KM; Isaacs SN
    Microbes Infect; 2005 Apr; 7(4):579-83. PubMed ID: 15848274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection by radioimmunoassay of antibodies in human smallpox patients and vaccinees.
    Ziegler DW; Hutchinson HD; Koplan JP; Nakano JH
    J Clin Microbiol; 1975 Mar; 1(3):311-7. PubMed ID: 170309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibody titers following revaccination with vaccinia virus.
    Heering SL; Shohat T; Vonsover A; Mendelson E; Lerman Y
    Public Health Rev; 1990-1991; 18(1):94-7. PubMed ID: 2132886
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioisotope precipitation tests with 14 C and 51 Cr labeled vaccinia antigens.
    Felsenfeld O; Dutta NK; Felsenfeld AD; Brannon RB
    Proc Soc Exp Biol Med; 1971 Oct; 138(1):149-51. PubMed ID: 5001503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.